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Background: Splenic enlargement is a component of the host response to malaria and may also influence the
genesis and progression of malarial anaemia. Few cross-sectional and no longitudinal studies have assessed the
relationship between splenic volume measured ultrasonographically and haemoglobin concentrations in children
with malaria.
Methods: Fifteen Papua New Guinean children with severe malarial anaemia (SMA; haemoglobin <50 g/L) and
ten with moderate malarial anaemia (MMA; 51–99 g/L) were recruited. The SMA patients were given intramuscular
artemether followed by oral artemisinin combination therapy (ACT), and were transfused one unit of packed cells
0.3-4.0 days post-admission. The MMA patients were treated with ACT. Splenic enlargement (Hackett’s grade,
subcostal distance and ultrasonographically determined volume) and haemoglobin concentrations were measured
on days 0, 1, 2, 3, 7, 14, 28, and 42.
Results: Associations between Hackett’s grade, subcostal distance and splenic volume were modest (rs ≤ 0.62,
P <0.001). Baseline splenic volume was not associated with age or haemoglobin (P ≥0.90). Mean splenic volume
had fallen by approximately 50 % at day 14 in children with MMA (P ≤0.011 vs days 0, 1 and 2), but there was no
change in the SMA group (P ≥0.30). There was no change in haemoglobin in the MMA group during follow-up but
a rise in the SMA group to day 7 (P ≤0.05 vs days 0, 1, 2, and 3) which paralleled the packed cell volume transfused.
Conclusions: Clinical assessment of splenomegaly is imprecise compared with ultrasonography. Serial splenic
volumes and haemoglobin concentrations suggest that the spleen does not influence post-treatment haemoglobin,
including after transfusion.
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Splenomegaly is one of the oldest known clinical manifes-
tations of malaria, having been recognized before the
discovery of the Plasmodium parasite [1]. Spleen size is
conventionally graded according to Hackett’s system [2]
with a score ranging from zero (no palpable spleen) to five
(massive enlargement extending towards the umbilicus;
see Fig. 1), but the vertical distance in centimetres (cm)* Correspondence: tim.davis@uwa.edu.au
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unless otherwise stated.from the lower costal margin in the mid-clavicular line
has also been used in studies of malaria [3]. The rate of
palpable splenomegaly can provide an indication of the
intensity of malaria transmission in endemic areas when
blood smears are unavailable [2, 4].
In patients with malaria, clearance of both parasitized
and non-parasitized red blood cells results in splenic
enlargement [5, 6] which in turn contributes, along with
intravascular haemolysis and dyserythropoiesis, to anaemia
[7–10]. Animal studies also show the pathophysiological
importance of splenic enlargement, with explanted and
post-mortem spleen sizes associated with the severity of
anaemia complicating malaria [11, 12]. The spleen is alsoThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Fig. 1 Hackett’s grading system for palpable splenomegaly
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maladaptive T and B cell immune responses. At its most
extreme, aberrant T-cell immune regulation of effective
humoral responses can lead to the massive splenic enlarge-
ment seen in hyper-reactive splenomegaly syndrome, a
major public health problem in some populations which is
associated with significantly increased mortality.
The complex three-dimensional shape of the spleen and
its position in the left upper quadrant of the abdomen
complicate accurate assessment of splenic volume. Since
Hackett’s grading or simple uniaxial measurement may
have insufficient sensitivity, ultrasonography has been
used as a more accurate alternative to clinical assessment
in parasitic diseases such as schistosomiasis [13]. In the
case of malaria, one small paediatric study showed that
spleen size by palpation significantly overestimated the
true incidence of splenomegaly as measured by ultrasound
[14]. Another study involving largely adults questioned
the value of splenic ultrasound as an aid to diagnosis and
did not find that ultrasonographically detected splenic
enlargement was associated with indices of severity [15].
By contrast, children with severe malaria anaemia (SMA;
haemoglobin concentration <50 g/L) in a second cross-
sectional paediatric study had higher splenic volumes
adjusted for total body surface area than those with
cerebral malaria, and a low splenic volume was associated
with subsequent mortality [16]. There have, however, been
no studies that have compared serial changes in splenic
volume after treatment assessed by ultrasound to both
simpler clinical measurements of spleen size and related
outcomes such as the development of malarial anaemia.
The spleen generally regresses in size within days to weeks
after anti-malarial treatment [17], but blood transfusion as
part of the management of SMA may promote persistentsplenic enlargement which could, in turn, attenuate the
benefits of transfusion [18].
In malaria-endemic areas of Papua New Guinea (PNG),
malarial anaemia associated with splenomegaly is a com-
mon clinical presentation. Despite a declining incidence of
malaria, 13 % of healthy asymptomatic PNG children have
splenomegaly [19], while anaemia, including SMA, is
common and multifactorial [20]. The aim of the present
study was to i) compare the traditional methods of splenic
size assessment with ultrasonographic volumetric meas-
urement; and, ii) evaluate serial changes in spleen size and
their haematological consequences in children with SMA
and moderate malarial anaemia (MMA).
Methods
Study sites, patients and approvals
Children with SMA were enrolled between March 2009
and May 2010 as participants in a prospective observational
study of severe paediatric illnesses that was conducted at
Modilon Hospital on the north coast of mainland PNG.
The clinical and laboratory characteristics of these patients
have been described previously [20]. In brief, they were
aged one to ten years and had Plasmodium falciparum
and/or Plasmodium vivax on light microscopy of a
peripheral blood smear together with severe anaemia.
Standardized case report forms containing demographic
and clinical information were completed by trained re-
search nurses. Clinical management, including blood
transfusions, were in accordance with World Health
Organization (WHO) [21] and PNG national guidelines
[22]. Intramuscular artemether was given at an initial dose
of 3.2 mg/kg of body weight, followed by daily doses of at
least 1.6 mg/kg until oral artemisinin combination therapy
(ACT) could be tolerated. Daily clinical assessments were
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specified time-points after discharge.
Children with MMA (haemoglobin 51–99 g/L) were
recruited at Mugil Health Centre located approximately
50 km from the township of Madang between April
2011 and June 2012. Screening for MMA was either part
of assessment for eligibility in a randomized trial of
ACT if the children were aged < five years [23] (none
of the present children met the inclusion criteria for
the clinical trial) or it was performed during routine
assessment of older children presenting with fever.
Inclusion criteria for the present study were i) age
between one and ten years; ii) P. falciparum and/or
P. vivax on peripheral blood smear; and, iii) no clinical
or laboratory evidence of severe malaria or another
infection. All children with MMA were treated with ACT
(artemether-lumefantrine) in accordance with the PNG
standard treatment guidelines [22].
The study was approved by the PNG Institute of
Medical Research Institutional Review Board and the
Medical Research Advisory Committee of the PNG
National Health Department (MRAC No. 11.07). Written
informed consent was obtained from a parent or guardian
of each study participant.
Clinical and laboratory procedures
All children were assessed on days 0, 1, 2, 3, 7, 14, 28,
and 42. At baseline, 500 μL venous blood was collected
into Microtainer® tubes (Becton Dickenson, Franklin
Lakes, USA) containing 0.39 mg disodium edetate and a
full blood count was performed using a Coulter counter
(ACT3 diff PAK, Beckman Coulter, Brea, USA). At each
subsequent follow-up visit, 250 μL blood was collected by
finger prick for Coulter counter haemoglobin measurement
and malaria microscopy. In children with SMA, an
additional 1–3 mL of blood was collected for bacterial
culture in BactecTM Peds PlusTM/F bottles (Becton
Dickinson) and incubated using an automated BactecTM
system. For malaria microscopy, standard procedures were
used [24, 25]. Giemsa-stained thick blood smears were
examined and parasitaemia quantified independently by
two skilled microscopists, with discrepancies adjudicated
by a senior microscopist.
Splenic size was assessed by palpation at each visit
with children in the supine position. Hackett’s grading
was determined in each case (see Fig. 1) and a tape
measure was used to determine the distance in cm from
the lower costal margin to the tip of the spleen in the
mid-axillary line. Ultrasonography in each SMA and
MMA patient and at each time point was performed using
a MicroMaxx Ultrasound System (SonoSite, Brookvale,
New South Wales, Australia) by the study clinician (ML)
or one of two trained nursing officers (SA and CB) with
the patient in the right recumbent position. These studystaff were all blind to the results of prior splenic volume
assessments and were not allocated systematically to indi-
vidual patients or time points. The spleen length (L),
width (W) and depth (D) were assessed using with the
probe in the longitudinal axis (L) and transverse axis (W
and D; see Fig. 2). With parental assistance, valid images
in each dimension were obtained from the majority of
children at each time-point. Splenic volume in cm3 was
calculated from the formula 0.524 × L (cm) × W (cm) × D
(cm) where L, W and D were obtained from the best
single image recorded [26, 27]. The within- and between-
operator variability in splenic volume has proved to be
acceptably low in other clinical contexts, including studies
involving children and those using a portable ultrasound
machine [28–31].Data analysis
The computer package IBM SPSS Statistics 20 (IBM
Corporation, Somers, NY, USA) was used for statistical
analysis. Data are summarized as mean ± SD or median
(inter-quartile range). Two-sample comparisons were by
Mann–Whitney U-test for continuous data and by Fisher’s
exact test for proportions. Bivariate associations between
variables were assessed using Spearman rank correlation
co-efficient (rs). For serial splenic volume and haemoglobin
data, missing data were imputed up to a maximum of
two values per patient using linear interpolation or
last observation carried forward. Differences between
groups at each time-point were assessed using generalized
linear mixed-effect models with gamma regression
(given the skewed nature of the splenic volume data)
and Bonferroni correction for pair-wise comparisons.
A two-tailed significance level of P <0.05 was used
throughout.Results
Baseline patient characteristics
Ten children with MMA and 15 with SMA were recruited.
Their baseline characteristics are summarized in Table 1.
All had P. falciparum mono-infections by expert micros-
copy at the time of enrolment, consistent with the greater
transmission, and stronger association with anaemia, of P.
falciparum vs P. vivax in the study area [20, 24]. Children
with SMA were significantly younger than those with
MMA, and they had a higher pulse rate, total white blood
cell count and platelet count. At baseline, splenic volumes
measured by ultrasound ranged from 14 cm3 to 265 cm3.
There was no significant difference between the two
patient groups in splenic volume, length below the
left costal margin or Hackett’s grade (P ≥0.50; see
Table 1). Baseline splenic volume was not associated with
haemoglobin concentration (rs = 0.02; see Fig. 3) or age
(rs = −0.03; P ≥0.90 in each case).
Fig. 2 Assessment of splenic volume using ultrasonography. Panel a illustrates measurement of spleen length in the longitudinal view. Panel b
shows measurement of width and thickness on the transverse view
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There was a rapid clearance of P. falciparum parasitaemia
in all children with MMA. Nine (90 %) were slide negative
within 24 h and all were slide negative by day 3. However,
gametocyte carriage persisted up to 14 days in two
children (20 %) and up to 28 days in one child (10 %).
None of the children with MMA required transfusion,
and all were discharged from hospital when they were
afebrile and aparasitaemic.
All children with SMA were blood slide negative for
malaria within 24 h. Gametocyte carriage persisted up to
28 days in one child. Blood cultures performed in children
with SMA were negative for bacterial pathogens in all
cases. All children with SMA were transfused one unit of
packed cells (300 mL) within four days of admission
(median 2.5 (range 0.3-4.0) days). There were no deaths
during follow-up in the SMA group.
Associations between splenic volume and clinical
assessment of splenic enlargement
To assess correlations between the traditional methods of
assessing splenic enlargement (distance below the left costal
margin and Hackett’s grade), combined measurementsfrom all children were obtained at all time-points.
Both the distance below the left costal margin and
Hackett’s grade were significantly associated with
splenic volume measured by ultrasound (rs = 0.62 and
0.59, respectively, P <0.001 in each case; see Fig. 4).
However, there was marked variation in both cases with,
for example, up to a ten-fold variation in splenic volume
at each Hackett’s grade. In those children without palpable
splenomegaly, the range of splenic volumes determined by
ultrasound (<110 cm3; see Fig. 4) was consistent with
mean values for normal children aged between one year
(42 cm3) and ten years (108 cm3) as assessed by computed
tomography [32].
Post-treatment changes in splenic volume and
haemoglobin
These were assessable in ten children with MMA and 12
with SMA with complete (including imputed) data to
day 14. In children with MMA, mean splenic volume did
not change initially but then fell after day 2 to approxi-
mately half the admission value at day 14 (P ≤0.011 vs days
0, 1 and 2; see Fig. 5). There was no equivalent change in
the two weeks after treatment in the SMA group despite
Table 1 Baseline clinical and haematology data in children with moderate and severe malarial anaemia
Moderate malarial anaemia Severe malarial anaemia P-
value(n = 10) (n = 15)
Age (months) 74 (58–87) 36 (32–49) 0.001
Male sex (%) 50 40 0.47
Axillary temperature (°C) 37.1 (36.3-38.6) 37.6 (36.6-38.0) 0.75
Pulse rate (beats/min) 97 (80–120) 128 (109–135) 0.003
Respiratory rate (breaths/min) 28 (23–33) 28 (28–39) 0.14
Blantyre Coma Score ≤4 (%) 0 20 0.20
Palpable spleen size (cm) 5.5 (3.7-7.0) 4 (2.0-7.9) 0.50
Hackett’s grade 2.5 (2–3) 3.0 (1.0-4.0) 0.93
Splenic volume (cm3) 84 (49–102) 54 (36–149)a 0.66
Total White cell count (109/L) 6.5 (3.1-9.1) 9.5 (6.5-18.8) 0.032
Lymphocytes (%) 46 (32–56) 40 (21–57) 0.42
Monocytes (%) 11 (7–18) 9.6 (6–12) 0.32
Granulocytes (%) 46 (32–53) 51 (32–72) 0.30
Total platelet count (109/L) 108 (50–221) 126 (43–211) <0.001
Haemoglobin (g/L) 77 (67–87) 46 (39–49) <0.001
Red blood cell count (1012/L) 2.7 (2.3-3.6) 2.2 (1.3-4.4) 0.42
Haematocrit (%) 22 18–26) 16 (10–25) 0.13
Mean cell volume (fL) 66 (62–77) 63 (55–83) 0.56
Mean cell haemoglobin (pg) 20 (19–24) 22 (19–27) 0.25
Mean cell haemoglobin concentration (g/L) 310 (284–324) 339 (308–380) 0.024
Red cell distribution width 17.5 (14.2-21.0) 19.1 (15.3-30.1) 0.42
P. falciparum density (/μL) 5776 (235–33,569) 600 (190–3388) 0.37
aTwo children in the SMA group did not have a valid splenic volume measurement
Data are medians (interquartile range) or percentages
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sons between time-points to day 14). The mean splenic
volume at day 7 was significantly higher than that in the
MMA group at that time (P = 0.043). By day 14, there was
no significant difference in splenic volume between the
two groups of children, a situation that was also observed
at days 28 and 42 (P >0.22).
There was no significant change in haemoglobin concen-
tration in the two weeks after treatment in the MMA group
(P ≥0.10 for pair-wise comparisons between time-points to
day 14; see Fig. 5). There was, however, a significant rise in
the relatively low haemoglobin concentrations in the SMA
group after day 3 (P ≤0.05 for day 7 haemoglobin vs days 0,
1, 2 and 3; see Fig. 5), so that levels in the SMA group were
higher than those in the MMA group at day 7 (P = 0.022).
By day 14, there was no significant difference in haemoglo-
bin between the two groups of children, a situation that
was also observed at days 28 and 42 (P >0.38).
Discussion
The present study demonstrates that splenic volume
determined by ultrasound in children presenting withfalciparum malaria in a hyperendemic area of coastal
PNG is variable and not associated with the degree of
anaemia at presentation. Simple clinical measures of
splenic enlargement (uniaxial splenic length below the
costal margin and Hackett’s grading) were only moderately
associated with splenic volume in this patient group, con-
sistent with the relatively low sensitivity and specificity of
palpation compared with ultrasonography in ascertaining
the presence and degree of splenomegaly regardless of the
underlying cause [33]. The temporal changes in splenic
volume after anti-malarial treatment differed by anaemia
status. In SMA patients, blood transfusion given during
the first four days of treatment was associated with a
stable mean splenic volume over the first two weeks
after treatment in the presence of a progressive rise
in haemoglobin to day 7. By contrast, splenic volume
decreased over the first two weeks after treatment in the
MMA group without a significant change in haemoglobin.
These observations suggest that transfusion attenuates
resolution of malaria-associated splenomegaly but also that
the spleen does not sequester a significant volume of trans-
fused blood in children with malaria and severe anaemia.
Fig. 3 Baseline splenic volume measured by ultrasound plotted against
haemoglobin concentration at study entry. The shaded area represents
severe malarial anaemia (haemoglobin <50 g/L). Two children with SMA
did not have valid baseline splenic volume measurements
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risk of other infections [35] and haemoglobinopathies
such as Southeast Asian ovalocytosis which are relatively
common in PNG [36], it is not surprising that most of
the present children had a degree of splenomegaly whenFig. 4 Splenic volume by ultrasound plotted on a logarithmic scale agains
Hackett’s grade (right) in children with moderate or severe malarial anaemrecruited and that this was not associated with features
such as age and haemoglobin. Nevertheless, palpation
with or without linear measurement of spleen size may
be adequate for clinical studies and epidemiological
surveys in which detection of splenic enlargement is
important [2–4], as long as its limitations are acknowl-
edged. Palpation for splenomegaly has a sensitivity of
between 28 and 77 %, and a specificity of between 62 and
99 %, in comparison with diagnostic imaging modalities
[33]. The greater specificity vs sensitivity is consistent with
the fact that Hackett’s grade 0 was consistently associated
with a normal splenic volume by ultrasound (<108 cm3)
[32] in the present study. Ultrasonography represents a
low-cost, non-invasive and accurate technique for
repeated assessment of splenic volume [28–31, 33]. In
the present study, novel ultrasonographic data were
collected relating to temporal changes in this variable,
which would not have been possible using simple
clinical assessments.
The most interesting observations in the present study
related to the relationship between serial ultrasonographic
splenic volume estimates and haemoglobin concentrations
after anti-malarial treatment. Reticuloendothelial clearance
of parasitized and non-parasitized erythrocytes [7, 37] as
well as acutely depressed erythropoiesis [10] can result in
an initial temporary post-treatment reduction in haemoglo-
bin [38]. This can be partially offset by splenic ‘pitting’, a
process which is strongly related to artemisinin treatmentt longitudinal distance in cm below the costal margin (left) and
ia
Fig. 5 Serial changes in splenic volume (upper panel) and
haemoglobin (lower panel) in children with MMA (●- - -●) compared
to those with SMA who were transfused (▲––▲) Data points are
means and SDs (vertical bars). *P <0.05 and **P <0.001 for between
group comparison using generalized linear mixed-effects models
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infected erythrocytes and returns these once infected
cells to the circulation. In children with MMA in the
present study, the initial fall in haemoglobin was not
significant and splenic volume did not change during
the first few days after anti-malarial treatment had
been started. The later significant reduction in splenic
volume was not associated with changes in haemoglobin
in this group.
By contrast, the mean haemoglobin concentration in
the SMA group increased between day 0 and day 7,
reflecting transfusions given during the first four
days [10]. A number of children with SMA had large
spleens at baseline (>100 cm3 in one third). It has
been shown that splenomegaly attenuates the efficacy
of blood transfusion through splenic sequestration of
erythrocytes [18], but this did not appear to be
present in the present children since splenic volume
did not increase significantly between days 0 and 3,
and the rise in haemoglobin (mean change 48 g/L
between days 0 and 7) was consistent with the volume of
blood transfused (expected change 52 g/L for a 12-kg
child receiving 300 mL packed cells [40]). However,there was also no reduction in splenic volume by day
7 post-treatment as was seen in the MMA group. This
suggests that transfusion attenuates the resolution of
malaria-associated splenomegaly, perhaps through mild or
subclinical immune activation resulting from red cell
incompatibility [41]. Alternatively, the children with
SMA had a larger sequestered biomass of parasitized
erythrocytes than those with MMA, which also con-
tributed to persistent splenomegaly through host immune
responses [42].
The present study had limitations. Determination of
within- (intra-day and inter-day) and between-observer
variation in ultrasonographic splenic measurements
were considered but would have been difficult in a
high-turnover paediatric ward and as part of home
follow-up visits in the rural tropics. The number of
trained operators both performing ultrasounds and
assessing splenic size clinically was, however, re-
stricted to limit measurement variability. There were
relatively small numbers of children in each group
but data collection over the six-week follow-up period
was complete in most patients. A larger sample may
have allowed an assessment of whether the inverse rela-
tionship between splenic volume and mortality found
in an African paediatric study [16] is also a feature in
PNG children but, consistent with the favourable outcome
in all the present patients, the case fatality rate asso-
ciated with severe malaria in Melanesian populations
is relatively low [43].Conclusions
The present study demonstrates that ultrasonographic
studies are feasible using a portable system in logistic-
ally challenging research environments. The recog-
nized limitations of clinical assessment of splenic size
were confirmed by the present data. Serial splenic
volume measurements and simultaneous haemoglobin
concentrations suggest that the spleen does not have
a major role in determining changes in post-treatment
haemoglobin, including in transfused patients with SMA.
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